Xenon
Manufacturing · Canada · 201-500 Employees
View Company Info for Free
Overview
Headquarters
3650 Gilmore Way Ste 200, Burnaby, Briti...Phone Number
(604) 484-3300Website
www.xenon-pharma.comRevenue
-Stock Symbol
XENEIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Xenon
Xenon is a clinical stage biopharmaceutical company founded in 1996 and headquartered in Canada. The company focuses on developing innovative therapeutics for patients with neurological disorders, particularly rare central nervous system conditions. Xenon specializes in creating novel neurology therapies that address areas of high unmet medical need, with a primary focus on treatments for epilepsy. The company maintains a product pipeline aimed at improving quality of life for patients with various neurological conditions through pharmaceutical innovation.Explore more
Xenon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xenon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Xenon is spiking on competitors!
Check if Xenon has recently received funding, and reach out quickly before it becomes old news!
Click to see if Xenon had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Xenon has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Xenon recently announced quarterly report
Xenon, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Xenon
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Xenon launches new products
Recommended Actions
Reach out to Masked Content who joined Xenon as Masked Content
Find 3 more new buyers
Compare Similar Companies to Xenon
Compare insights from companies similar to Xenon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Xenon is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xenon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xenon.
Xenon financials insights
Gather financial insights about Xenon, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Corporate Investment
$5.3M
2014
Stock Offering
$38.2M
2016
Stock Offering
$25.9M
2018
Stock Offering
$50M
Stock Offering
$63M
2019
Corporate Investment
$50M
2020
Stock Offering
$69M
Xenon Tech Stack
A closer look at the technologies used by Xenon
Most Recent Scoops
Hiring Plans
Xenon has more open roles in Human Resources than it has had at any time in the past 12 months. Areas of expertise include: Human Resource Management, HR Operations, Full-Cycle Recruitment, and Workday (Software).
Hiring Plans
Project
Xenon has reported that among patients enrolled in the seven-year open-label extension study of azetukalner from its Phase II program, approximately 40% of those on the drug for more than four years have achieved 12 months of seizure freedom, in a population where the median patient had failed six prior anti-seizure medicines and was still experiencing seizures every other day.
Pharmaceuticals, Clinical Operations
Project
Xenon has announced plans to file a New Drug Application (NDA) for azetukalner in focal-onset seizures in Q3 2025, with a targeted commercial launch in H2 2027.
Pharmaceuticals
Hiring Plans
Xenon has announced plans to deploy approximately 75 sales representatives in the US to support the commercialization of azetukalner, targeting epileptologists and a select group of general neurologists, supplemented by non-personal promotion to build brand and company awareness.
Advertising, Sales
Event
Pharmaceuticals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Xenon
Sign Up For FreeTo access detailed company insights
Xenon is a clinical stage biopharmaceutical company founded in 1996 and headquartered in Canada. The company focuses on developing innovative therapeutics for patients with neurological disorders, particularly rare central nervous system conditions. Xenon specializes in creating novel neurology therapies that address areas of high unmet medical nee... Read More
